Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effect of rifampicin and clarithromycin on the CYP3A activity in patients with Mycobacterium avium complex.

Akiyama N, Inui N, Mori K, Nakamura Y, Hayakawa H, Tanaka S, Uchida S, Namiki N, Watanabe H, Suda T.

J Thorac Dis. 2019 Sep;11(9):3814-3821. doi: 10.21037/jtd.2019.09.06.

2.

[Non-tuberculous mycobacteriosis. What has been coming out].

Kajiki A.

Kekkaku. 2011 Feb;86(2):113-25. Japanese.

PMID:
21404655
3.

Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.

Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.

J Infect Chemother. 2018 Apr;24(4):315-318. doi: 10.1016/j.jiac.2017.10.022. Epub 2017 Dec 7.

PMID:
29223615
4.

Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.

Shin SH, Jhun BW, Kim SY, Choe J, Jeon K, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01105-18. doi: 10.1128/AAC.01105-18. Print 2018 Oct.

5.

[Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].

Kawata N, Kawahara S, Tada A, Takigawa N, Shibayama T, Soda R, Takahashi K.

Kekkaku. 2006 Apr;81(4):329-35. Japanese.

PMID:
16715941
6.

Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China.

Zhao X, Wang Y, Pang Y.

Infect Genet Evol. 2014 Oct;27:332-8. doi: 10.1016/j.meegid.2014.07.032. Epub 2014 Aug 15.

PMID:
25131955
7.

Comparing the Genotype and Drug Susceptibilities between Mycobacterium avium and Mycobacterium intracellulare in China.

Zheng HW, Pang Y, He GX, Song YY, Zhao YL.

Biomed Environ Sci. 2017 Jul;30(7):517-525. doi: 10.3967/bes2017.068.

8.
9.

Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.

Litvinov V, Makarova M, Galkina K, Khachaturiants E, Krasnova M, Guntupova L, Safonova S.

PLoS One. 2018 Sep 17;13(9):e0203108. doi: 10.1371/journal.pone.0203108. eCollection 2018.

10.

[Genetic research about Mycobacterium avium complex].

Ogawa K.

Kekkaku. 2011 Feb;86(2):61-8. Japanese.

PMID:
21404652
11.

In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.

Huang CC, Wu MF, Chen HC, Huang WC.

J Microbiol Immunol Infect. 2018 Oct;51(5):636-643. doi: 10.1016/j.jmii.2017.05.001. Epub 2017 Jun 28.

12.

18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex.

Furuta K, Ito A, Ishida T, Ito Y, Sone N, Takaiwa T, Yokoyama T, Tachibana H, Arita M, Hashimoto T.

J Infect Chemother. 2016 Sep;22(9):622-8. doi: 10.1016/j.jiac.2016.06.009. Epub 2016 Jul 16.

PMID:
27430867
13.

The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.

van Ingen J, Egelund EF, Levin A, Totten SE, Boeree MJ, Mouton JW, Aarnoutse RE, Heifets LB, Peloquin CA, Daley CL.

Am J Respir Crit Care Med. 2012 Sep 15;186(6):559-65. doi: 10.1164/rccm.201204-0682OC. Epub 2012 Jun 28.

PMID:
22744719
14.
15.

Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.

Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H.

Ann Am Thorac Soc. 2014 Jan;11(1):23-9. doi: 10.1513/AnnalsATS.201308-266OC.

PMID:
24298907
16.

Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin.

Yamamoto F, Harada S, Mitsuyama T, Harada Y, Kitahara Y, Yoshida M, Nakanishi Y.

Jpn J Antibiot. 2004 Feb;57(1):124-33.

PMID:
15116577
17.

GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY.

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00516-19. doi: 10.1128/JCM.00516-19. Print 2019 Aug.

PMID:
31167842
18.

A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.

Morimoto K, Hasegawa N, Izumi K, Namkoong H, Uchimura K, Yoshiyama T, Hoshino Y, Kurashima A, Sokunaga J, Shibuya S, Shimojima M, Ato M, Mitarai S.

Ann Am Thorac Soc. 2017 Jan;14(1):49-56. doi: 10.1513/AnnalsATS.201607-573OC.

PMID:
27788025

Supplemental Content

Support Center